BullFrog AI Holdings (BFRG) Times Interest Earned (2022 - 2026)
BullFrog AI Holdings' (BFRG) quarterly Times Interest Earned came in at 598.0 in Q2 2026, little changed on a YoY basis from 595.91 in Q2 2025, and up 75.18% quarter-over-quarter from 2409.42 in Q4 2025.
Powered by 
Analysis
BullFrog AI Holdings (BFRG) Times Interest Earned (2022 - 2026) Analysis & Trends
BullFrog AI Holdings (BFRG) has reported Times Interest Earned for 5 consecutive years, with 598.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Times Interest Earned changed 0.35% year-over-year to 598.0; the trailing twelve-month figure through Jun 2026 stood at 852.59 (down 25.22% YoY), and the FY2025 full-year result was 1171.55, down 193.97% from the prior year.
- Times Interest Earned grew to 598.0 in Q2 2026 per BFRG's latest filing, from 2409.42 in the prior quarter.
- Across five years, Times Interest Earned topped out at 5.16 in Q3 2022 and bottomed at 2409.42 in Q4 2025.
- Historically, Times Interest Earned has averaged 573.81 across 5 years, with a median of 365.6 in 2024.
- The widest YoY moves for Times Interest Earned: up 40.81% in 2023, down 11565.34% in 2023.
- Over 5 years, Times Interest Earned stood at 5.18 in 2022, then tumbled by 11565.34% to 604.69 in 2023, then slumped by 45.67% to 880.86 in 2024, then sank by 173.53% to 2409.42 in 2025, then soared by 75.18% to 598.0 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered 598.0, 2409.42, and 1017.29 for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 5.22 |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | -42.08 |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 117.59 |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | -493.00 |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 2.82 |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | - |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | -0.08 |
| 10 | BullFrog AI Holdings | 9.27 Mn | 2.35 Mn | 106,899.00 | -598.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -598.00 |
| Dec 31, 2025 | -2,409.42 |
| Sep 30, 2025 | -1,017.29 |
| Jun 30, 2025 | -600.11 |
| Mar 31, 2025 | -2,026.23 |
| Dec 31, 2024 | -880.86 |
| Sep 30, 2024 | -365.60 |
| Jun 30, 2024 | -212.93 |
| Mar 31, 2024 | -600.59 |
| Dec 31, 2023 | -604.69 |
| Sep 30, 2023 | -226.49 |
| Jun 30, 2023 | -141.77 |
| Mar 31, 2023 | -19.75 |
| Dec 31, 2022 | -5.18 |
| Sep 30, 2022 | -5.16 |
| Jun 30, 2022 | -7.25 |
| Mar 31, 2022 | -33.37 |